Future mechanistic studies are required to understand which pathways lead to enhanced apolipoproteins oxidation and the biological implications of these findings with regards to the possibility that enhanced ApoC‐III oxidation could lead to functional consequences in terms of lipoprotein metabolism, and MetS/MASLD complications. This evidence concerns the gene APOC3 and metabolic syndrome.